Sumit Aggarwal Email and Phone Number
Sumit Aggarwal work email
- Valid
- Valid
Sumit Aggarwal personal email
Sumit Aggarwal phone numbers
I am a seasoned executive with over 25 years of experience in the pharma, biotech, diagnostic, and medical technology sectors. I have a track record of raising over $250 million in public equity, venture, and debt funding, leading business turnarounds, and executing strategic partnerships and acquisitions. I have an MBA in Finance and Strategy from Cornell University, Johnson School, one of the top business schools in the US.Currently, I am the President and CEO of Eloxx Pharmaceuticals, a biotech company developing novel therapies for rare diseases and cancers driven by nonsense mutations. I joined Eloxx in April 2021, after engineering the sale of Zikani Therapeutics, a Harvard spin-off that I led as President and CEO, generating a 3X return for Series A-1 investors. At Eloxx, I am focused on advancing our pipeline, expanding our global footprint, and delivering value to our shareholders, patients, and partners. My mission is to leverage my expertise in rare diseases, oncology, genomic tools, diagnostics, and devices, and my passion for innovation, to bring life-changing treatments to the market.
Eloxx Pharmaceuticals
View-
President And CeoEloxx Pharmaceuticals Apr 2021 - PresentWatertown, Massachusetts, Us
-
President And CeoZikani Therapeutics Mar 2019 - Apr 2021Venture backed Harvard spin-off developing novel macrocyclic ribosome modulators for treating rare mutationally driven inherited diseases and cancers. Engineered a sale to Eloxx Pharmaceuticals generating a 3X return for Series A-1 investorsAsked by investors to takeover as President and CEO in March 2019 with a charter to recommend and implement a strategy that could justify continued investment. Successfully turned around the company, reset cap table and valuation raising $7.5M Series A-1 in March 2020 from Roche, Advent and Gurnet Point funding the company through 20020 and enabling raise of a Series B. Repositioned and rebranded company to rare inherited diseases and cancers driven by nonsense mutations. Validated with compelling proof of functional efficacy in Cystic Fibrosis Class 1, FAP, APC mutant colon cancer, RDEB and JEB. Additionally, secured term sheet for antibiotic program from top 10 pharma company and renegotiated companies' university license agreement
-
Chief Financial Officer And Chief Business OfficerZikani Therapeutics Sep 2018 - Dec 2019Initially recruited as the CFO and Chief Business Officer to raise a Series B for the now legacy gram-negative antibiotic company (Macrolide) with only 6 months of cash remaining. Released $8M note tranche in Q4 2018 from all five original investors to extend cash runway to Dec 2019. Evaluated venture debt funding options, reduced cash burn and improved overall effectiveness of finance processes.
-
Acting President And Chief Financial OfficerProgenity, Inc. May 2015 - Sep 2018$200M+ private genetic services company (500+ employees) offering proprietary pre-natal genetic testing services to OB/GYN with a direct to physician sales force of 200.Recruited by the Executive Chairman and former CEO of Sequenom to reinvigorate growth and profitability after a >40% reimbursement cut to its NIPT (downs syndrome) test while building its pipeline and strengthening the balance sheet. Raised $125million in additional debt and equity capital in Q4 2017. • Exceeded Revenue growth goals by 3% and 10% respectively in 2016 and 2017 exiting 2017 with $235M in revenues• Exceeded EBITDA goals by $24 million and $28million in 2016 and 2017 with highest ever EBITDA margins of >20%
-
Senior Healthcare Analyst And Portfolio ManagerMillennium Partners Oct 2013 - Mar 2015New York, Ny, UsManaged a new Long/short sleeve of investments in Medical devices, genetic tools, diagnostic services and healthcare payers and providers.Applied unique approach to analyzing key growth inflection points. Top investments generated 3x+ returns -
Equity Analyst And Portfolio ManagerAdage Capital Management May 2007 - Sep 2012Managed market neutral global life science tools, diagnostic products and services and medical technology fund. Evalauted and invested in public and private companies. Senior analyst on Large Pharma and biotech team -
Vice President And Senior Healthcare AnalystHartford Investment Managent Company Jan 2006 - May 2007Founding member of start-up investment venture. Grew assets to $680million. Manage investments in publicly traded global healthcare companies and Indian Equities
-
Associate PrincipalMckinsey Jul 1998 - Dec 2005UsLeader in firm’s global healthcare practice. Served clients in the US, Europe, India and Japan. Advised across range of areas including commercial strategies, product launches, business building, M&A, capital markets. Worked in the New York and London offices and consulted with clients in the North America, Europe, India and Japan -
Lead Process ConsultantLurgi Gmbh 1994 - 1996Led 5-member design team building new chemical plant for private Indian chemical company -
Graduate TraineeGail (India) Limited 1993 - 1994New Delhi, Delhi, In
Sumit Aggarwal Skills
Sumit Aggarwal Education Details
-
Cornell Johnson Graduate School Of ManagementFinance And Strategy -
Indian Institute Of Technology, KharagpurChemical Engineering
Frequently Asked Questions about Sumit Aggarwal
What company does Sumit Aggarwal work for?
Sumit Aggarwal works for Eloxx Pharmaceuticals
What is Sumit Aggarwal's role at the current company?
Sumit Aggarwal's current role is President and CEO @ Eloxx Pharmaceuticals | Transformative Change Leader, Innovator and Investor.
What is Sumit Aggarwal's email address?
Sumit Aggarwal's email address is sa****@****tal.com
What is Sumit Aggarwal's direct phone number?
Sumit Aggarwal's direct phone number is +161786*****
What schools did Sumit Aggarwal attend?
Sumit Aggarwal attended Cornell Johnson Graduate School Of Management, Indian Institute Of Technology, Kharagpur.
What skills is Sumit Aggarwal known for?
Sumit Aggarwal has skills like Strategy, Private Equity, Valuation, Due Diligence, Pharmaceutical Industry, Equities, Investments, Management, Offshoring, Investment Management, Risk Management, Business Strategy.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial